LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Udupa, Karthik Subramanaya"
  2. AU=Zinzula Luca
  3. AU="Shah, Pallavi"
  4. AU="Kirschnick, Laura Borges"
  5. AU="Nobuyuki Sakai"
  6. AU="Robert van Deursen"
  7. AU="Sentinella, Alexander T"
  8. AU=Budhiraja Rohit
  9. AU="Tonjes, M B"
  10. AU="Vande More, A M"
  11. AU="Gangireddy, Pavan Kumar Reddy"
  12. AU="Marlier, Arnaud"
  13. AU="Nerone, Marta"
  14. AU="Hou, Ping"
  15. AU=Sommerstein Rami AU=Sommerstein Rami
  16. AU="Zocchi, Kent"
  17. AU="Pandey, Jitendra Kumar"
  18. AU=Nzila Alexis
  19. AU="Vallurupalli, Anusha"

Search results

Result 1 - 1 of total 1

Search options

Article: Cytogenetics and Revised International Staging System (R-ISS): Risk Stratification in Multiple myeloma - A Retrospective Study in Indian Population.

Udupa, Chethana Babu K / Udupa, Karthik Subramanaya / Pai, Ananth / Sherigar, Prathika

Iranian journal of pathology

2020  Volume 15, Issue 3, Page(s) 182–188

Abstract: Background & objective: Cytogenetic abnormalities in Multiple myeloma (MM) has emerged as the most important factor that determine the prognosis and survival. Fluorescence in situ hybridization (FISH) can detect a greater number of cytogenetic ... ...

Abstract Background & objective: Cytogenetic abnormalities in Multiple myeloma (MM) has emerged as the most important factor that determine the prognosis and survival. Fluorescence in situ hybridization (FISH) can detect a greater number of cytogenetic abnormalities as compared to conventional karyotyping and hence has become the standard test in determining genetic abnormalities in MM. The present study was planned as there is an unmet need to find out various cytogenetic abnormalities and to implement them in prognostic stratification by Revised International Staging System (R-ISS) among Indian population.
Methods: A single institution retrospective study was conducted among a total of 117 patients newly diagnosed as Multiple Myeloma. They were analyzed for various cytogenetic abnormalities by using interphase FISH (iFISH) and were staged according to Revised International Staging System (R- ISS).
Results: Out of the 117 patients studied, deletion 17p13 (p53) was present in 16 patients (13.67%). Thirty patients (25.64%) showed deletion 13q14.3. Three patients (2.56%) were detected to have t(4:14).Two patients (1.7%) had t(11:14) and t(14:16), respectively. Total of 19 patients (16.23%) in our study exhibited high risk cytogenetics and two among them had more than one high risk cytogenetic abnormalities. There was a 66.4% moderate correlation between ISS-III and high-risk cytogenetics which was statistically insignificant. Of the total 117 patients, 37 (31.62%) were staged R-ISS III.
Conclusion: High risk cytogenetics was found in 16.23 % of our study population and del 17p13 was the most common high-risk cytogenetic abnormality. Of the studied subjects, 31.62% had R-ISS III, which is significantly higher compared to western population.
Language English
Publishing date 2020-04-21
Publishing country Iran
Document type Journal Article
ZDB-ID 2478278-6
ISSN 1735-5303 ; 2345-3656
ISSN 1735-5303 ; 2345-3656
DOI 10.30699/ijp.2020.105128.2078
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top